Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
364 results
  1. NLM Digital Collections - FDA oversight 
    Publication: [Toronto, Ontario] : Thomson Reuters, 19-December-2022
    resource.nlm.nih.gov/9918645959006676
    ... the FDA approved Orencia (abatacept) for the prophylaxis (prevention) of acute graft versus host disease (aGVHD), a condition that occurs when donor bone ...
  2. NLM Digital Collections - Antilymphocyte serum mode of action and clinical applicability 
    Publication: Fort Sam Houston, Tex. : The Academy, [1975]
    resource.nlm.nih.gov/7604254A
    ... investigated in the prevention of graft rejection and prevention of graft versus host disease and lymphocyte serum. As many of you know, ...
  3. NLM Digital Collections - Manufacture of blood components using a pathogen reduction device in blood establishments : ... 
    Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, November 2021
    resource.nlm.nih.gov/9918351275906676
    ... used as an alternative to gamma irradiation for prevention of transfusion-associated graft versus host disease (TA-GVHD). 2 Contains Nonbinding Recommendations 5. Can ...
  4. NLM Digital Collections - Health Care Reform (cont'd.) 
    https://resource.nlm.nih.gov/101662437X1583
    ... OF MEDICINE AND SURGERY VOLUME 329 Original Articles Prevention of ... Disease ........cccevveenee 1225 N.J. CHAO AND OTHERS Overwhelming ...
  5. NLM Digital Collections - AIDS Tracer M, 9/5/1984-9/28/1984 
    https://resource.nlm.nih.gov/101637321X17
    ... of the cases in the 483 ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH ... T-cell antibody (0-0-5%). No anti-graft-versus-host disease prophylaxis was given after transplantation. Rapid engraftment was ...
  6. NLM Digital Collections - Hospital literature index (Volume 49) 
    resource.nlm.nih.gov/7807587X36
    ... and the risk of related-donor transfusion-associated graft-versus-host disease. McMilin KD, et al. Transfus Med Rev 1993 ... and the risk of related-donor transfusion-associated graft-versus-host disease. McMilin KD, et al. Transfus Med Rev 1993 ...
  7. NLM Digital Collections - Gene therapies for sickle cell disease : final evidence report 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, August 21, 2023
    resource.nlm.nih.gov/9918697383806676
    ... Drug Administration g/dL gram per deciliter GVHD Graft-versus-host disease HLA Human leukocyte antigen HSCT Hematopoietic stem cell ... HSCT has a risk of graft failure/rejection, graft-versus-host disease (GVHD), acute complications during the transplant process, and ...
  8. NLM Digital Collections - Betibeglogene autotemcel for beta thalassemia : effectiveness and value : final evidence ... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, July 19, 2022
    resource.nlm.nih.gov/9918506283406676
    ... cel, HSCT places the recipient at risk for graft versus host disease. As we heard from patients living with TDT ... that it does not impose a risk of graft-versus-host disease or rejection. Despite these risks, advances in HSCT ...
  9. NLM Digital Collections - Hospital literature index (Volume 43) 
    resource.nlm.nih.gov/7807587X30
    ... marrow transplantation: effect on infectious complications, fever and graft versus host disease. Skinh0j P, et al. Scand J Infect Dis ... marrow transplantation: effect on infectious complications, fever and graft versus host disease. Skinh0j P, et al. Scand J Infect Dis ...
  10. NLM Digital Collections - Analysis of supply, distribution, demand, and access issues associated with immune globulin ... 
    Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, 2007
    resource.nlm.nih.gov/101615447
    ... pneumonia of infectious or idiopathic causes, and acute graft-versus-host disease after transplantation Source: Orange et al., 2006 An ... reduce the incidences of infection and to prevent graft versus host disease, in which the new donor cells attack the ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last